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Left Ventricular Flow Patterns after Percutaneous Edge-to-Edge Mitral 
Valve Repair: An in vitro Study 
Morteza Jeyhani 
Percutaneous mitral valve edge-to-edge repair is a viable solution in high-risk patients 
with severe symptomatic mitral regurgitation. However, the generated double-orifice 
configuration poses challenges for the evaluation of the hemodynamic performance of the 
mitral valve and may alter flow patterns in the left ventricle during diastole. The purpose 
of the present in vitro study is to provide new insight into the spatial-temporal 
hemodynamics of the flow distal to simulated percutaneous edge-to-edge repair by 
employing a high resolution, flow diagnostic method, Phase Locked and Time Resolved 
Digital Particle Image Velocimetry inside the LV. 
 
A custom-made mitral valve was developed and two configurations were tested: a single 
orifice valve with mitral regurgitation and a double-orifice mitral valve configuration. 
The hemodynamic performance of the valve was evaluated using Doppler 
echocardiography and catheterization. The flow patterns in the left ventricle were 
investigated using Particle Image Velocimetry. 
 
Edge-to-edge repair significantly reduced the regurgitant volume. There was a good 
agreement between Doppler and catheter transmitral pressure gradients. There was a 
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good match between maximal velocity measured by Doppler and particle image 
velocimetry. Vortex development in the left ventricle during diastole was significantly 
different after repair. 
 
There was a good agreement between Doppler and catheter measurements of transmitral 
pressure gradient following simulated edge-to-edge repair. Flow in the left ventricle was 
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Our body needs oxygen to continue the process of life. Heart -a beating muscular pump 
about the size of your fist- connected to a network of arteries and veins pumps blood 
through the whole body. This complex system pumps at a rate of approximately 10 pints 
of blood per minute to both the body and the lungs.  
 
The oxygen-rich blood from the aorta goes through the arteries and capillaries to convey 
blood to the different tissues, and disposes of waste products, like carbon dioxide. De-
oxygenated blood returns to the right side of the heart through inferior and superior vena 
cavas. The right atrium ejects blood into the right ventricle through the tricuspid valve, 
and is then pumped through the pulmonary valve to the pulmonary artery. After passing 
through the lungs, blood goes to the left side of the heart through four pulmonary veins 
and reaches the left atrium (LA). Blood continues its journey into the left ventricle (LV) 
through the mitral valve (MV) and, finally, it is ejected into the aorta and the arterial 
system through the aortic valve.  
 
Mitral valve and left ventricle filling phase (diastole) 
The mitral valve is the main focus of this thesis. Its role is to ensure a strict, 
unidirectional movement of blood from the left atrium to the left ventricle. The left 
ventricular diastolic filling phase is characterized by a first jet emerging from the LA 
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through the MV, into the LV cavity as a result of ventricular expansion (E-wave), which 
is followed by a transitional phase (diastasis), and a second jet resulting from LA 
contraction (A-wave) (Nichols et al., 2011). 
 
In this chapter, the MV anatomy, physiology and pathology are presented, followed by a 
discussion of the most common MV diseases and their proper repairs. 
 
1.2 Mitral Valve Anatomy 
 
The mitral valve comprises two leaflets, papillary muscles, chordae tendineae, the mitral 
annulus and the left ventricular myocardium (Figure 1.1). Imperfections in any of these 
components may result in blood flowing back into the left atrium during ventricular 
ejection. 
 
Figure 1-1: An anatomic drawing of heart (https://www.themitralvalve.org). 
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1.2.1 Valvular Leaflets 
 
The MV has two leaflets. The anterior leaflet has a semi-circular shape and the posterior 
leaflet has a quadrangular shape, which both are attached at their bases to the 
fibromuscular ring. The posterior leaflet is divided into three individual scallops with two 
indentations that are identified as P1, P2, and P3. The edge of the anterior leaflet is 
artificially divided into three portions, A1, A2, and A3 (Figure 1.2) (Lancellotti et al., 
2010). 
 
Figure 1-2: Segmental anatomy of the mitral valve (https://www.themitralvalve.org). 
 
1.2.2 The Annulus 
 
The mitral annulus constructs the anatomical junction between the left atrium and the left 
ventricle, and is the location of the insertion of the anterior and posterior leaflets. The 
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mitral annulus itself is divided into posterior and anterior segments. The anterior segment 
is attached to the fibrous trigons and the posterior segment is less developed. The mitral 
annulus has a saddle shape.  
 
1.2.3 Subvalvular Apparatus 
 
The subvalvular apparatus consists of chordae tendinae and papillary muscles. The 
chordae tendinae connect papillary muscles to the MV leaflets. The connection points are 
located between the free edge and the base of the leaflets. Rupture, calcification, fusion 
and redundancy of the chordae can cause mitral regurgitation. There are two papillary 
muscles arising from the apical area of the left ventricle. The anterolateral papillary 
muscle is mostly comprised of one head, or body, and the posteromedial papillary muscle 
may have two heads, or two bodies. Rupture, fibrotic elongation, or the displacement of 




Figure 1-3: Subvalvular apparatusin LV (https://www.themitralvalve.org). 
 
1.2.4 Left Ventricle (LV) 
 
The papillary muscles are attached to the lateral wall of the LV, so any change in 
ventricular geometry may affect the mitral coaptation area. As a consequence, the LV is 
an important part of the MV complex (O‟Gara et al., 2008). 
 
1.3 Mitral Valve Pathology 
 
Most cases of mitral valve defects are degenerative, although rare cases can be 
congenital, due to rheumatic fever, or resulting from ischemic heart disorder. 
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There are several different types of heart disease that can affect MV function. The 
following section describes the three most frequent pathologies.  
 
1.3.1 Mitral Stenosis 
 
Mitral valve stenosis is a narrowing of the mitral valve opening area. The leaflets are 
usually thicker, leading to abnormal LV filling during diastole, and an increase in LV 
work. Rheumatic fever is the most common cause of mitral stenosis. 
 
1.3.2 Mitral Valve Prolapse 
 
Mitral valve prolapse is a condition in which MV leaflets do not close tightly because the 
mitral valve leaflets are floppy (Figure 1.4). As a result, when LV contracts (systolic 
phase), one or more of the leaflets lose out into the LA and blood may flow back into the 
LA, leading to potentially significant regurgitation. In some cases, MV prolapse does not 





Figure 1-4: Mitral valve prolapse (https: //www.nhlbi.nih.gov). 
 
1.3.3 Mitral Valve Regurgitation (MR) 
 
Mitral regurgitation is a condition in which the mitral valve leaflets do not close securely 
during the systole (sometimes also called valvular insufficiency). This incomplete 
systolic closure leads to backflow to the LA. This pathological condition increases LV 
work, since, for each ejection phase, the LV has to compensate for the volume of blood 
flowing back into the LA, instead of through the aortic valve.  MR can leads to LV 
dilatation, an increase in left atrium pressure, and pulmonary hypertension (Calafiore et 
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al., 2005). Approximately 500,000 people in North America alone are suffering from MR 
and each year. 
 
There are two types of MR: acute and chronic. The acute type is characterized by 
pressure gradient in pulmonary veins which cause pulmonary edema. In chronic MR, the 
left atrial size increases slowly, so there is no pressure gradient in the pulmonary veins. 
Progressive ventricular dilation leads to dysfunction of the ventricle and, eventually, heart 
failure.  
 
1.4 Mitral Valve Repair 
 
 Surgical valve repair is the best solution for symptomatic patients with severe MR 
(Bakker et al. 2013).  Several reports have shown the superiority of MV repairs over MV 
replacements, including better preservation of LV function, lower thrombus formation, 
and increased survival rates (Gillinov et al., 2008). Approximately 50,000 mitral valve 
repairs are performed in the United States. (Rogers et al. 2011; Dang et al. 2005). 
 
Several techniques can be used to repair a MV: Annuloplasty, quadrangular resection, re-








In this method, a cloth-covered ring is inserted around the mitral valve in order to ensure 
optimal coaptation of the valve leaflets, and to minimize regurgitation. Severe undersized 
annuloplasty can, however, lead to mitral stenosis (Figure 1.5). 
Figure 1-5: Mitral valve annuluplasty (https://www.themitralvalve.org). 
1.4.2 Quadrangular Resection 
 
One of the problems seen in mitral regurgitation is prolapse of the middle portion of the 
posterior leaflet (P2) that it may results from the rupture of chordae tendineae. In such 
case quadrangular resection is a method in which the loose, redundant segments of the 
leaflets are removed (Figure 1.6. I). 
1.4.3 Re-Suspension of Leaflets 
 
In cases with elongated or broken chords valve‟s leaflet needs artificial chordae tendineae 
to prevent prolapsing; also sometimes additional chords are required to support loosen 





Figure 1-6: I: Mitral valve quadrangular resection (https://www.themitralvalve.org); II: Artificial chordae 
(https://www. ctsnet.org). 
 
1.4.4 Percutaneous Edge-to-Edge Repair 
 
Although the above mentioned approaches to surgical repair have already been applied 
successfully, recent European reports show that as many as 49% of patients with MR are 
denied surgery because they are considered to be “high risk” patients, due to 
comorbidities, LV dysfunction, or age (Jamieson et al., 1999; Vahanian et al., 2007; 
Mirabel et al., 2007; Estevez-Louriero et al., 2013). For these patients, the most recent 
guidelines set by the European Society of Cardiology suggest considering percutaneous 
Edge-to-Edge mitral valve Repair (PEtER). EtER consists of locally suturing together the 
diseased free edges of the posterior and anterior MV leaflets exactly where the 
regurgitant jet is located (Fucci et al., 1987). Percutaneous EtER originates from the 
surgical approach developed by Alfieri et al. (2001). Application of the EtER for cases 
with regurgitant jets in the center of the MV leads to a double orifice (DO) valve 
configuration. For the cases in which MV lesion is localized near to the commissure, 
surgical technique of edge-to-edge repair results in a single orifice with a rather smaller 
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area that is named paracommissural repair (Alfieri et al., 2005); (Figure 1.7). The proper 
implementation of this technique in treating valve regurgitation has led to low risk, and 
good early and mid-term clinical results and can be used as a standardized procedure 
(Maisano et al., 2000). 
 
 
Figure 1-7: The percutaneous EtER technique. Right: Double orifice (DO). Left: Paracommissural repair. 
 
This procedure can be minimally invasive by using a clip (MitraClip©). The MitraClip 
(Abbot Vascular, Santa Clara, California, USA) approach is an option to treat MR with 
determined clinical success (Rogers et al., 2011). The MitraClip device mimicks the 
EtER technique. The device is composed of a cobalt chromium implant with two arms 
and two grippers that are used to snatch the edges of the two leaflets in order to improve 





Figure 1-8: Schematic of MitraClip (Rogers et al., 2013). 
 
Successful clip placement can be achieved in the majority of patients (typically above 
95%) (Van den Branden et al., 2012). Under such valve opening configurations, the 
assessment of MV hemodynamics is challenging and little is known regarding induced 
flow patterns in the LV (Loh et al., 2013). 
 
1.5 Literature Review 
 
1.5.1 Flow in Left Ventricle with a Healthy Mitral Valve 
 
Pedrizzetti et al. (2005) numerically evaluated the optimization of the swirling flow in the 
human LV under physiological conditions.  They showed that the location of the mitral 
valve is optimal in order to ensure the smooth continuity between cardiac phases (diastole 




Schiller et al. (2006) tried to simulate blood flow in the left part of the human heart to see 
the changes in flow patterns and energy loss. They used a virtual heart model, which was 
created based on a real human heart. By the aim of MRI got time-depending geometry 
and intraventricular flow from healthy human LV and left atrium. They performed the 
numerical flow calculation with a finite volume method. Experiments that consist of a 
silicon ventricle with the exact geometry of the virtual ventricle with the PIV and LDA 
measurement were used for validation. Combination of MRI –flow measurements and 
numerical simulation data show the effect of procedural influences. Furthermore, the 
numerical study provides them with the opportunity to perform intraventricular energy 
estimations.     
 
Hong et al. (2008) tried to evaluate the possibility of analyzing the left ventricular vortex 
by using contrast echocardiography and determining the LV vortex flow in MR cases, as 
well as with patients with LV systolic dysfunction. This study included twenty-five 
patients that underwent contrast to evaluate vortices and velocity vectors.  In this study, 
they quantified LV vorticity with the aid of contrast echocardiography in normal and 
dysfunctional LV during systole.     
 
1.5.2 Flow in Left Ventricle with Mitral Valve Repaired Using Edge-
to-Edge Technique   
 
Percutaneous EtER originates from the surgical approach developed by Alfieri et al. 
(2001). It is currently performed using a MitraClip (Abbot Vascular, Santa Clara, 
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California, USA), and involves clipping the free edges of the valve leaflets at the non-
coaptation zone of the regurgitant jet (Hilberath et al., 2013).  
 
Edge-to-edge repair of the mitral is expected to significantly modify the flow patterns in 
the LV and leads to a double-orifice MV opening. Successful clip placement can be 
achieved for most patients (typically above 95%) (Van den Branden et al., 2012). Under 
such valve opening configuration, the assessment of MV hemodynamics is challenging 
and little is known regarding induced flow patterns in the LV (Loh et al., 2013). 
Maisano‟s group have performed interesting numerical simulations on surgical edge-to-
edge approach. The results were very informative, and demonstrated that the velocity 
profile downstream of the double-orifice MV is similar to a healthy, single-orifice valve 
with the same geometrical orifice area (Maisano et al., 1999). Furthermore, they showed 
that the generated “camel-like” velocity profile can lead to up to 35% variation in the 
estimation of mitral transvalvular pressure gradient depending on the location of the 
measurements. Such flow patterns have also been confirmed by Hu et al. (2010), through 
3D numerical simulations, using finite volume method, of the flow in the LV following 
edge-to-edge repair. They also showed that the double orifice configuration creates two 
strong jets with the maximum of 1.05 m/s and small-scale vortices that are rapidly 
convected towards LV apex. Moreover, they showed that the flow in the LV, following 
edge-to-edge repair, induces elevated viscous energy losses. They also showed that 




From a physiological point of view, the abnormal flow pattern in the LV, following edge-
to-edge repair, lead to elevated shear regions in the LV. This can trigger the 
thromboembolic process. Interestingly, Orban et al. (2012) reported the case of a patient 
with successful percutaneous edge-to-edge MV repair who developed a large left 
ventricular thrombus four days after the repair.  
 
1.5.3 Summary of Literature Review 
 
This literature review has shown that: 
- The flow in a normal left ventricle is optimized in order to allow for a smooth 
continuity between filling and ejections phase with minimal energy loss. 
- Edge-to-edge mitral valve repair significantly alters flow patterns in the left ventricle, 
reduces its filling efficiency, and can potentially lead to thrombus formation. 
- Only few numerical studies have investigated flow patterns in the left ventricle 
following edge-to-edge mitral valve repair. There are, so far, no in vivo, or experimental 




The main objective of this thesis is to investigate experimental flow patterns in the left 
ventricle following simulated edge-to-edge repair. The hemodyanmics of the mitral valve 
will be evaluated using standard clinical approaches and the flow patterns will be 
measured using particle image velocimetry. 
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Chapter 2 : In vitro Experimental Setup and 
Conditions 
 
2.1 Experimental Facility 
 
2.1.1  ViVitro System 
 
For the purpose of this study, a ViVitro pulse duplicator (ViVitro Labs, Victoria, BC, 
Canada) was used (Figure 2.1). This system is capable of reproducing normal human 
physiological conditions in terms of pressure and flow waveforms.   
 
Figure ‎2-1: ViVitro pulse duplicator (ViVitro Labs, Victoria, BC, Canada). 
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This system is powered by a piston-in-cylinder pulsatile pump. The setup includes an 
atrium chamber that contains a mitral valve, a silicone model of the left ventricle, and a 
rigid glass model of the ascending aorta. The arterial system consists of a compliance 
chamber and a resistance. Flow through the MV was measured using an electromagnetic 
flow meter (Carolina Medical Electronics, King, NC, USA) with 10% accuracy on the 
full-scale (5 ml/min to 20 l/min). Pressure measurements were performed using Millar 
MPC 500 transducers (Millar Instruments, Houston, TX, USA), with an accuracy of +-
0.025% on the full scale (-50 mmHg to 300 mmHg). 
 
Figure 2.2 sketches the close-loop circulation circuit. It comprises the resistive element 
(simulating peripheral body resistance) and a compliance chamber (simulating the 
elasticity of the arteries).  
 
Figure ‎2-2: Scheme of close-loop circulatory system. 
 
This chapter also discusses the different components of the left heart simulator. 
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2.1.2 Valves Configurations 
One of the most challenging parts of this project was developing the model of a mitral 
valve. The system includes a trileaflet bioprosthetic valve in the mitral position. The 
shape of the model valve is far from the shape of an anatomical mitral valve. However, 
developing an anatomically realistic mitral valve would require adding models of the 
papillary muscles and the chordae to the model, limiting the flow visualization by particle 
image velocimetry. To overcome this, two approaches have been considered; 1) 
developing rigid models of mitral valves, before and after edge-to-edge repair, and; 2) 
developing a custom-made mitral valve and an original solution to avoid leaflet prolapse. 
 
Figure ‎2-3: a) Side view b) Top view of healthy valve configuration. c) Side view d) top view of 
percutaneous edge-to-edge repaired mitral valve configuration. 
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Several measurements have been done on the rigid model. The results were very 
informative but the lack of consideration of the dynamic movement of the leaflets was a 
significant limitation. For the custom-made mitral valve, several designs have been 
tested. A mitral valve annulus has been designed and rapid-prototyped.  For the valve 
leaflets, in terms of material properties, the silicon-made leaflets were first tested. 
However, their durability during the testing was not satisfactory, as the leaflets eventually 
tore. New leaflets made from rubber bands directly cut from a balloon, were then tested. 
The durability of the rubber valves was significantly better compared to the silicon 
valves. The problem of leaflet prolapses was solved using a new approach. Four thin 
wires (diameter of 0.3 mm) were positioned at the level of the mitral annulus. As a 
consequence, during left ventricle ejection, the wires prevented the valve leaflets from 
flipping back into the left atrium. It was verified that the size of the wires was small 
enough to avoid significant disturbance in the flow. Indeed, the computed Reynolds 
number (based on peak E-wave velocity and wire diameter) for the flow around the wires 
was 142 and, under such conditions, a steady separation bubble should exist downstream 
of the wires. 
 
On this custom-made mitral valve, two configurations have been tested; 1) a regurgitant 
valve, and; 2) a repaired valve using percutaneous edge-to-edge technique. A 4 mm width 
patch at the middle portion of the leaflets simulated the latest configuration. The width of 
the patch was selected to mimic the cobalt-chromium clip used in transcatheter edge-to-
edge MV repair using the MitraClip system (Abbott Vascular, Santa Clara, California). 
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The geometrical orifice area of the valve before percutaneous EtER was 572 mm
2
, while 
the total geometrical orifice area of the generated double-orifice was 245 mm². 
 
 









2.1.3 Particle Image Velocimetry 
 
Particle Image Velocimetry, or PIV, is an optical technique allowing instantaneous 
velocity measurements on a whole plane (Raffel et al., 2006). A standard PIV system 
requires a laser source, CCD Camera(s) and light scattering particles.  
 
The principle of PIV is quite straightforward; the laser emits light that is scattered by the 
particles. Two consecutive images of the particles, with a determined time delay t, are 
recorded by a high-speed camera. The images are then divided into interrogations zones 
(typically 32 by 32 pixels, or less) and cross-correlation is then performed between the 
two images. The peak of the cross-correlation in each interrogation region leads to the 
most probable displacement of the particles within specific zone. Knowing the time delay 
t between the images, the local velocity can easily be determined (Figure 2.6).  
 
In this work, PIV has been used in order to investigate the velocity field inside the LV for 




Figure ‎2-6: PIV setup (Dantecdynamics.com). 
2.1.3.1 Laser 
 
The PIV LaVision system (LaVision GmbH, Goettingen, Germany) was used in 
combination with a dual cavity Nd:YLF laser (Litron Lasers, Warwickshire, UK) with a 
maximum pulse energy of 10 mJ at 527 nm and a maximum repetition rate of 20 kHz. 
The laser sheet, with a thickness of approximately 1 mm; was positioned parallel to the 





Figure ‎2-7:Schematic of the ViVitro System cardiac simulator addressing the position of laser sheet 
illumination and position of CCD camera. 
 
2.1.3.2  Seeding Particles 
 
The seeding particles are an important and critical part of PIV system because the 
particles must match the fluid properties. The particles must be small enough to be able to 
follow the fluid flow (reduction of Stokes drag), but at the same time, large enough to 
scatter enough light. Another important characteristic required from the seeding particles 
for cardiovascular flow applications is their time response. The particles have to be 
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capable of rapidly responding to sudden variations in flow velocity. In this work, Hollow 
Glass Spheres of 10 µm diameters and a density of 1.1 g/cm³ were found to adequately 




A high-speed digital camera (Phantom V9.1, Vision Research, NJ, USA) with 1000 fps, 
at a maximal resolution of 1632×1200 pixels was used for recording the images. The 
maximal recording frequency achievable at full resolution is then 500 Hz. In order to 
optimize the cross-correlation of the PIV measurements for each instant of measurement, 
the time step between two consecutive laser pulses (t) was modified to satisfy the ¼ law 
(t range: 100 µs to 700 µs) (Raffel et al., 2006). Both phase-locked and time-resolved 
measurements have been performed. For phase-locked measurements, a total of 200 
images was recorded for each phase, and was then averaged. Multi-pass cross-
correlations were used with an initial interrogation region size of 32×32 pixels, and a 
final size of 16×16 pixels, with 50% overlapping. The final spatial resolution was 0.49 
mm × 0.49 mm.  
 
2.1.4 Doppler Echocardiography 
 
In order to compare the results found in this work with in vivo data that is available in the 
literature, Doppler echocardiographic measurements have been performed. Doppler 
echocardiography measurements were performed using an Acuson 128 XP/10 
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(California, USA) and V219 (2.5 MHz) probe (Figure 2.8). The beam was carefully 
aligned with the main jet direction. For the double-orifice configuration, the beam was 
aligned with one of the orifices. For all measurements, continuous-wave Doppler was 
used and the following parameters were determined: 1) Peak E-wave velocity; 2) Peak 
and mean transvalvular pressure gradient using simplified Bernoulli equation (Eq. 2.1). 
                                




Figure ‎2-8: a) Doppler echocardiography measurements were performed using an Acuson 128 XP/10 





2.1.5 Catheter Measurements 
 
Pressure waveforms in left heart cavities were recorded using three standard Millar 
catheters MPR-500 with the accuracy of ±0.025% on the full scale (-50 ml/min to 20 
l/min).  Additionally, pressure measurements were performed upstream and downstream 
of the mitral valve using a new pressure wire developed by HemoDynamix Inc. Based on 
fiber-optic technology, the prototype designed by HemoDynamix Medical Systems 
incorporates 4 sensors, spaced 2 cm apart, within an envelope of 0.71 mm of outside 
diameter. This diameter is small enough for the device to be guided to heart valve regions 
within a standard guiding catheter (which has an inner diameter of 0.89 mm or 0.035”). 
Apertures were created on the envelope using a laser so that the pressure sensors have 
access to the surrounding environment. Radio-opaque marker bands indicate the location 
of pressure sensors. The device is terminated with a flexible “J-tip” to reduce the 
possibility of damage to heart tissues (Figure 2.9).  
 




Figure ‎2-10: The evolution chassis unit. 
The device was connected to a FISO (evolution Chassis) designed computer-controlled 
signal conditioner and data acquisition to be able to read pressures (Figure 2.10). On the 
prototype used in the study, only two sensors were functional. One sensor was located 
upstream of the MV model, and a second one at the tip of the valve leaflets. For the 
double-orifice case, the probe was passed through one of the orifices. 
 
Mitral flow waveform was measured using an electromagnetic Carolina Medical 
Electronics flow probe. The internal diameter of the probe is defined at 28 mm, and 
matches the aortic and MV flow channels in the system. A FM501 flow meter was used 
with the flow probe. 
 
2.2 Experimental Conditions 
The measurements were performed under physiological conditions: heart rate of 70 bpm, 
arterial systolic and diastolic pressures of 120 mmHg and 80 mmHg, stroke volume of 70 
mL. The circulatory fluid was a mixture of water and glycerol with a density of 1080 
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kg/m3 and viscosity of 3.5 cP to simulate the physiological characteristics of the blood 
under high shear rate conditions. 
 
Phase-Locked PIV measurements were performed at 8 different instants during diastole 
(See Figure 2.11). 
  







Chapter 3 : Results 
 
In this section, the experimental results obtained with the two configurations of the mitral 
valve, the regurgitant mitral valve and the mitral valve following edge-to-edge repair, are 
presented and discussed.  
 
3.1  Mitral Flow Waveform 
 
Figures 3.1 and 3.2 show flow waveform through the mitral valve before and after 
percutaneous edge-to-edge repair. It is worth noting that simulated EtER successfully 
reduced mitral valve regurgitant volume (integral of the flow rate moving back from the 
left ventricle to the atrium during systole) from 34 ml to 15 ml (56% reduction). So, in 
this work, a severe mitral regurgitation was simulated and the edge-to-edge repair 
approach led to a reduction in its severity to mild mitral regurgitation. This is consistent 
with in vivo findings were several studies have shown that percutaneous edge-to-edge 
repair successfully reduced mitral regurgitation from grade 4 (severe mitral regurgitation) 
to grade 3 or 2 (moderate or mild mitral regurgitation) (Bakker et al., 2013; Van 
den Branden et al., 2007). It is important to note that only in a limited number of cases, 
percutaneous edge-to-edge repair led to more than two-grade reduction in mitral 





Figure ‎3-1: Mitral flow waveform before simulated percutaneous EtER. Red color zone shows that the 






Figure ‎3-2: Mitral flow waveform before simulated percutaneous EtER. Red color zone shows that the 
regurgitant volume to 15 ml. 
 
3.2  Doppler Echocardiography and Catheter 
Measurements 
 
A major concern with percutaneous edge-to-edge repair is the possibility of inducing a 
significant flow restriction through the mitral valve during LV systole. Indeed, the 
significant reduction in the mitral valve geometrical orifice area following edge-to-edge 
repair might lead to a mitral stenosis. However, clinical evaluations of mitral valve 
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performance following percutaneous edge-to-edge repair is challenging due to the double 
orifice configuration of the valve. In this work, unique experiment measurements using 
both Doppler echocardiography and catheterization allow a direct comparison between 
the pressure losses induced by the mitral valve during systole, following edge-to-edge 
repair.    
 
The beam of Doppler was aligned with one of the orifices and, for all the measurements 
performed, continuous-wave Doppler was used and the following parameters were 
determined: velocity-time integral (VTI); mean transmitral pressure gradient 
(MnGRAD); peak E-wave velocity and peak A-wave velocity. The table 3.1 shows the 
obtained data: 









0.54 4.6 1.65 1.30 
0.54 4.6 1.58 1.28 
0.50 4.3 1.65 1.28 
 
          
                                                             
For catheter measurements, one sensor was located upstream of the MV model, and a 
second one at the level of the tip of the value leaflets. The probe was passed through one 
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of the orifices for the double-orifice case. The comparison between Doppler 
echocardiography and catheter measurements is shown in the figure 3.3: 
 
Figure ‎3-3: Comparison between Doppler and catheter transmitral pressure gradients. There is a good 
agreement between the two measurements and the EtER seems not to induce a severe mitral stenosis. 
 
The figure displays peak and mean transmitral pressure gradients (TMPG), as measured 
by catheter and Doppler ultrasounds. There was good agreement between the results. The 
peak of TMPG for the Doppler is 9 mmHg, which is close to the peak of TMPG 
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measured by catheter (7 mmHg). The mean TMPG by the Doppler is 4 mmHg while it 
was 3 mmHg by catheter. 
 
3.3  PIV Measurement 
 
3.3.1  Phase-Locked Measurement  
 
PIV measurements were taken at eight different instants (phases) during the cardiac 
cycle. Here, the three most important instants are discussed: peak of E-wave; mid-
diastasis; and peak of A-wave. 
 
3.3.1.1 Velocity Pattern and Profiles 
 
Figure 3.4 shows the flow pattern inside the LV at the peak of E-wave. The simulated 
percutaneous edge-to-edge repair induced a clear modification in the flow inside the left 
ventricle. A double jet develops with a significant increase in maximal velocity from 0.4 










Figure ‎3-4: Velocity patterns measured by particle image velocimetry at peak of E-wave. The 
measurements were performed before (left) and after (right) simulated percutaneous edge-to-edge mitral 
repair. The induced double jet configuration clearly appears with a deeper penetration inside the LV. 
 
Figure 3.5 shows the comparison of the velocity profile measured 15 mm downstream of 
the tip of the MV leaflets and at the peak of the E-wave.  A clear difference between the 
case of regurgitant mitral valve and following percutaneous edge-to-edge repair can be 
observed. A „double flat‟ velocity profile is generated following percutaneous edge-to- 
edge repair. Such velocity profiles increases shear layer zones and might predispose to 




Figure ‎3-5: Velocity profile measured by particle image velocimetry 15 mm downstream of the tip of the 
mitral valve leaflets for the peak of E-wave. The measurement was performed before and after 
percutaneous edge-to-edge mitral repair. The induced double jet configuration significantly increases the 
magnitude of the velocity and generates a double jet configuration. 
 
Figure 3.6 represents flow patterns inside the LV during diastasis. The reduction in mitral 
inflow leads to a reduction in maximal jet velocity compared to peak E-wave: 0.25 m/s 
for regurgitant mitral valve and 0.8 m/s following percutaneous edge-to-edge repair. The 
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velocity profiles measured 15 mm downstream of the tip of the mitral valve leaflets 
remain unchanged with a reduced velocity magnitude (Figure 3.7). 
 
 
Figure ‎3-6: Velocity patterns measured by particle image velocimetry at diastasis. The measurements were 
performed before (left) and after (right) simulated percutaneous edge-to-edge mitral repair. The induced 








Figure ‎3-7: Velocity profile measured by particle image velocimetry 15 mm downstream of the tip of the 
mitral valve leaflets for the diastasis. The measurement was performed before and after percutaneous edge-
to-edge mitral repair. The induced double jet configuration significantly increases the magnitude of the 
velocity and generates a double jet configuration. 
 
The velocity magnitude at the peak of A-wave of flow rate through the mitral valve 
increases as a result of left atrium contraction. As a result, the velocity magnitude in the 
LV increases again to reach 0.3 m/s for mitral regurgitation case and 1.4 m/s following 




Figure ‎3-8: Velocity patterns measured by particle image velocimetry at peak of A-wave. The 
measurements were performed before (left) and after (right) simulated percutaneous edge-to-edge mitral 




Figure ‎3-9: Velocity profile measured by particle image velocimetry 15 mm downstream of the tip of the 
mitral valve leaflets for the A-Wave. The measurement was performed before and after percutaneous edge-
to-edge mitral repair. The induced double jet configuration significantly increases the magnitude of the 









Plotting velocity streamlines allows for a better representation of flow structures in the 
left ventricle before and after percutaneous edge-to-edge repairs. 
 
Figure 3.10 represents velocity streamlines at the peak of E-wave, diastasis, and peak of 
A-wave. In the case of mitral regurgitation, a large coherent structure develops in the left 
ventricle (a cross section of vortex ring). This structure is convected towards the left 
ventricle apex, and occupies a large portion of the ventricle cross-section at the end of 
diastole. Such a large coherent structure has been shown to play an important role in 
storing energy during diastole (Pedrizzetti et al., 2005). For the case following 
percutaneous edge-to-edge repair, a smaller coherent structure is developed in the left 
ventricle and is rapidly convected towards the apex. No large-scale coherent structure is 
present in the left ventricle prior to the ejection phase. This abnormal flow configuration 





Figure ‎3-10: Velocity streamlines measured by particle image velocimetry at three different instants. The 
measurements were performed before (left) and after (right) simulated percutaneous edge-to-edge mitral 
repair. EtER induced significant modifications in vortex development in the LV. following EtER the 





3.3.1.3 Total Kinetic Energy and Viscous Dissipation of Energy 
 
A way to evaluate the performance of the left ventricle is to compute the total kinetic 
energy and the viscous dissipation of energy. 
For kinetic energy per unit of mass at each phase (i), is computed as: 
   ∑
 
 




 ∑                    
  
                              
 
where ρ is the density of the fluid, u is the velocity component in x-direction, v is the 
velocity component in y-direction, and ∆A is the interrogation area in PIV. All local 
kinetic energies at each spatial location are added to represent the total kinetic energy at a 
specific instant in the cycle.  
 
Figure 3.11 shows a map of the spatial distribution of kinetic energy at the peak E, and A 




Figure ‎3-11: Average kinetic energy at peak E and A waves for mitral regurgitation case and percutaneous 
edge-to-edge case. 
 
Such maps show that most of the kinetic energy is concentrated in the inflow jet region. 
Interestingly, the case simulating percutaneous EtER displays significant regions in the 
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flow field where the kinetic energy is almost zero. Such regions might predispose for 
thrombus formation.   
Figure 3.12 represents the evolution of total kinetic energy, spatially averaged, for both 
cases investigated in this study, at eight different phases.  
 
Figure ‎3-12: Total kinetic energy for the seven different instants during diastole and one instant during 
systole. This figure scaled differently for two cases (the different instants correspond to the different phases 
as illustrated on figure 2-11). 
Although the trend for total kinetic energy between mitral regurgitation and following 
percutaneous edge-to-edge repair is not significantly different, the amplitude for 
percutaneous edge-to-edge repair is around two times of magnitude higher than for mitral 
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regurgitation. This means that left ventricle filling, following edge-to-edge repair, is 
performed at higher energetic cost.  
Another interesting flow parameter to evaluate is the viscous dissipation of energy 
(Graw, et al. 2002):  


















   
                             
where   represents the dynamic viscosity of the fluid, ΔA stands for the interrogation 
area, u is the velocity component in the x-direction and v is the velocity component in the 
y-direction; dx and dy are the spatial resolutions in the x and y directions, respectively. 
Table 3.2 shows the difference in viscous dissipation at each phase between mitral 
regurgitation and percutaneous EtER. Increase in viscous dissipation of energy may lead 
a less efficient ventricular pumping function. Furthermore, less energy can be stored in 









Table ‎3-2: Representative of viscous dissipation of energy for different instants with the unit of Pa/s. 


















































3.3.1.4 Reynolds Shear Stress 
 
Reynolds Shear Stress (RSS) is averaged over 200 cycles. The assessment of RSS helps 
predicting the risk for shear induced blood components damage. This damage can be 
caused by prolonged collision and conflict of blood components, including the collision 
of red blood cells and platelets between each other, or the surface of the valve (Kheradvar 
et al. 2012). The regions with the potential of high Reynolds shear stresses may lead to 
hemolysis and platelets activation (Kameneva et al., 2004). 
 
The RSS is calculated based on the velocity fields obtained from PIV measurements. RSS 
is not fixed by the rotation of the coordinate, so the major Reynolds stresses are 
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calculated along the principal axes (Baldwin et al. 1993). RSS (Eq. 3.4) and Reynolds 
normal stress (Eq. 3.5 and Eq. 3.6) are computed according to: 
   ̅̅ ̅̅ ̅  
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N represents the number of images taken at each phase. Each velocity vector is 
decomposed into its mean component and its fluctuating velocity. So,  ́ and  ́ are 
fluctuating components of a velocity vector in x-direction and y-direction, respectively. 
The major RSS is computed as: 
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Figure 3.13 shows the RSS field at the peak of E-wave and A-wave. Edge-to-edge repair 




 at the 




 at the peak of A-wave. While, for the case with mitral 








  at the peak of A-wave. These figures also show that edge-to-edge repair creates 
high shear stress layers that might damage red blood cells, or activate platelets with risks 
of hemolysis, or thrombus formation in the LV. Interestingly, Orban et al. (2012) have 
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already reported a case of thrombus formation in the LV following a successful 
percutaneous edge-to-edge repair.    
 
Figure ‎3-13: Reynolds shear stress at the peak of E and A waves for MR and percutaneous EtER cases 




3.3.2  Time-Resolved Measurement  
 
Time-resolved particle image velocimetry measurements were also performed in order to 
investigate flow dynamics in the left ventricle in the case of mitral regurgitation and 
following percutaneous edge-to-edge repair. Of interest here is the evolution of the 
vorticity field during left ventricle filling phase. Other results, including velocity fields 
and viscous energy dissipation derived from time-resolved measurements can be found in 
Appendix.  
 
3.3.2.1 Vortex Dynamics inside the Left Ventricle 
 
Figure 3.14 represents the vorticity field at four instants during left ventricle filling phase. 
The maximum of vorticity is 320 s
-1
. Dispersed small scale coherent structures can be 




Figure ‎3-14: Vorticity magnitude for t=0.099 s, t=0.159 s, t=0.271 s and t=0.440 s for the MR case. 
 
The trend is significantly different for the case with percutaneous edge-to-edge repair. 
The vorticity magnitude is significantly higher than for the mitral regurgitation case and 
reaches a maximum of 1800 s
-1
.  A vortex ring is formed early in diastole and is rapidly 
convected towards the apex. At instant t=0.165 s, a vortical structure can also be 
observed between the two jets emerging from each orifice of the repaired mitral valve 




Figure ‎3-15: Vorticity magnitude for t=0.110 s, t=0.165 s, t=0.285 s and t=0.458 s for the EtER case. 
 
Time resolved measurements allow for the evaluation of speed at which coherent 
structures are convected into the LV during one cycle and mainly during early diastolic 
phase (E-wave).  For this, a space-time plot is represented for each case investigated in 
this work. For this purpose, the time evolution of the axial velocity along a line passing 
through the mitral orifice (one of the two orifices for the case with percutaneous edge-to-
edge repair) is plotted. Then, the location of the maximal velocity along the line is 
obtained at each instant and a linear regression allows for the estimation of the speed of 




Below figures represent the space-time velocity distribution during E-wave. In these 
figures the slope of dashed line shows the propagation of the vortices for MR case; the 
estimated propagation velocity is 15 mm/s (Figure 3.16). For EtER case the propagation 
velocity is significantly higher and reaches 99 mm/s (Figure 3.17). 
 
 



















Chapter 4 : Conclusion and Future Works 
 
The key findings of this study are: 1) there was a good agreement between Doppler and 
catheter transvalvular pressure measurements in the case of double orifice MV 
configuration; 2) Percutaneous EtER significantly modified flow patterns and vortex 
dynamics in the LV.  
 
Recent studies have shown that about half of the patients with symptomatic severe MR 
are not referred to surgery mainly because of age or the presence of comorbidities (Van 
den Branden et al., 2007). For such patient, percutaneous EtER using MitraClip appears 
as a viable solution. EVEREST I (Endovascular Valve EtER Study I) demonstrated 
mainly the safety and feasibility of the MitraClip. However, the results from EVEREST 
II on 179 patients have shown that percutaneous EtER does not outperform surgery in 
symptomatic patients with MR. Although the number of major adverse events was 
significantly lower in patients with a MitraClip, the rate of surgery/reoperation was 
significantly higher compared to the surgical group (Munkholm-Larsen et al., 2013). 
As a consequence, the recent guidelines from the European Society of Cardiology and the 
European Association for Cardio-Thoracic Surgery suggest that MitraClip has been used 





4.1 Hemodynamic Performance Following 
Percutaneous EtER  
 
The double orifice configuration generated by EtER poses challenges for the evaluation 
of MV function. In this study, we showed that there was a good agreement between the 
maximal velocity measured by Doppler and PIV (1.60 m/s vs.1.58 m/s). Furthermore, we 
found a good match between Doppler and catheter transmitral pressure gradients 
(Peak TMPG: 9 mmHg vs. Catheter: 7 mmHg; Mean TMPG: 4 mmHg vs. 3 mmHg). The 
values for TPMG obtained in this study are in good agreement with in vivo data from the 
literature.  In 84 patients with EtER, Hilberath et al. (2013) found a peak TMPG of 
10.7±0.5 mmHg and a mean TMPG of 4.3±0.2 mmHg, while Hermann et al. (2009) 
reported a mean TMPG of 4.1±2.2, and Divchev et al. a mean TMPG of 3.6±1.5 mmHg.   
 
4.1.1 Location of Doppler Measurements 
 
Maisano et al. (2000) showed numerically that up to 35% can be obtained in the 
estimation of TMPG depending on the location of the measurements. In this study, we 
found even larger difference between the jet velocity and the central line velocity. At the 
peak of the E-wave, the jet velocity was around three times higher than the central line 
velocity, while at the peak of the A-wave, the jet velocity was about six times 
higher. Alignment of the Doppler probe is therefore essential in order to limit 
measurement errors. Another finding was that the jet velocity remained at its maximal 
value for around two orifice diameters (around 20 mm). As a result, if pulsed Doppler is 
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used to evaluate MV function following EtER, the results are less affected by the 
longitudinal positioning of the probe inside the LV.    
 
4.1.2 Flow Patterns in the LV Following Percutaneous EtER  
 
The results of this study showed significant modifications in flow patterns in the LV 
following EtER. Except for the development of a double jet configuration, the vortex 
structures in the LV were significantly different from a normal LV 
filling. EtER generated smaller vortex structures that were rapidly convected towards the 
apex and significantly contributed in dissipating flow energy. This energy lost as heat is 
not available during LV systole to transport blood flow through the arterial 
system. These findings are in agreement with the results obtained numerically by Hu et 
al. (2010).  
 
4.2 Future Works 
 
Left human heart ventricle is one of the most sophisticated parts in cardiovascular system 
from the hemodynamics and fluid mechanics point of view.  
 
In this in vitro study, blood flow behavior under pathological condition after valve edge-
to-edge repair was investigated. This experimental study revealed interesting results 
regarding the flow behavior inside the LV. However, future studies performed using 3D 
stereoscopic PIV should be performed in order to more accurately investigate the flow in 




Also from a fluid mechanics point-of-view, vortex formation and reconnection for flow 
conditions mimicking percutaneous edge-to-edge repair will be an interesting area to 
investigate.    
 
Finally, from a clinical point-of-view the effect of mitral valve area reduction following 
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Viscous Dissipation of Energy 
 
In a viscous fluid flow the viscosity of the fluid will take energy from the kinetic of fluid 
and transform it to the internal energy (heat). This irreversible process named viscous 
dissipation. In order to calculate the Viscous Dissipation of Energy respect to the 
previous equation we have: 


















   
                              
Where   is representing the dynamic viscosity of the fluid.     and    are spacing 
between velocity vectors. This equation (Eq. A.1) obtained from (Graw, et al. 2002). 
Below graph represents the viscous dissipation of energy in systole and diastole of the 
LV before intervention as MR case. This graph discloses how the viscosity of the fluid 
during the cardiac cycle took energy from the kinetic energy (motion) of the fluid and 
transforms it to the irreversible internal energy. During the cardiac cycle it changes 
around 0.02 Pa/sec and as it is unfolded for two critical moments of each cardiac cycle, 
E-Wave and A-Wave, the changes was not enormous and viscous dissipations were 




Figure A-1: Viscous dissipation of energy for MR case in one cardiac cycle. 
 
Figure A.2 illustrates viscous dissipation for the cardiac cycle after simulating the 
percutaneous EtER of mitral valve. This graph reveals the trend has changed completely 
and strongly asserts that how this operation has altered the blood flow inside the LV. The 
whole variation of the viscous dissipation is around 0.8 Pa/sec and this variation for the 
E-Wave and A-Wave in compare to the other moments of the cycle is around 63% to 
87% that might endanger blood components and damage them. Also the variations during 

















 Velocity Pattern 
 
Figure A.3 represents the velocity magnitude for four different time of t=0.099, 0.159, 
0.271 and 0.440 seconds in one cardiac cycle (t=0.857 s) for MR case. These moments 
respectively are stand for the peak and deceleration of E-Wave, diastasis and peak of A-
Wave.  
In all the mentioned instants distribution of the velocity magnitude is smooth and has 
changed for 0.3 m/s with higher rates along the ejected mitral jet.  In t=0.099 s and 
t=0.440 s the higher velocity is distributed at the level of the valve.  
 
Figure A-3: Velocity magnitude for t=0.099 s, t=0.159 s, t=0.271 s and t=0.440 s for the MR case. 
 73 
 
Figure A.4 roughly shows the same instants at the times of t=0.110, 0.165, 0.285 and 
0.458 seconds. Contrary to the previous case the velocity pattern inside the LV is harsh 
and higher velocity sharply diffused along the jets with 60% to 70% difference by the 
value of very close neighbouring regions.  
 
Figure A-4: Velocity magnitude for t=0.110 s, t=0.165 s, t=0.285 s and t=0.458 s for the EtER case. 
 
 
